MedTrace Logo

Topical Penlac Nail Lacquer for Onychomycosis in Children

NCT01419847 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-08-18

No results posted yet for this study

Summary

Five months of therapy is sufficient to treat onychomycosis in children. Topical therapy of onychomycosis in children with Penlac nail lacquer has comparable efficacy and a superior cost and safety profile compared to systemic therapy.

Conditions

  • Onychomycosis

Interventions

DRUG

Ciclopirox

DRUG

Placebo

Sponsors & Collaborators

  • Rady Children's Hospital, San Diego

    lead OTHER

Principal Investigators

  • Sheila F Friedlander, MD · Rady Children's Hospital, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-03-31
Primary Completion
2005-12-31
Completion
2006-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01419847 on ClinicalTrials.gov